Urology
Volume 75, Issue 4 , Pages 768-772 , April 2010

Osteoblast-specific Factor 2 Expression in Prostate Cancer-associated Stroma: Identification Through Microarray Technology

  • Bungo Furusato

      Affiliations

    • Center for Prostate Disease Research, Department of Surgery and United States Military Cancer Institute, Uniformed Service University of the Health Science, Bethesda, Maryland
    • Department of Genitourinary Pathology, Armed Forces Institute of Pathology, Washington, District of Columbia
    • Corresponding Author InformationReprint requests: Bungo Furusato, M.D., and Isabell A. Sesterhenn, M.D., Armed Forces Institute of Pathology, 6825 16 th Street NW, Washington, DC 20306
    • ,
  • Toshiyuki Tsunoda

      Affiliations

    • Faculty of Medicine, Department of Cell Biology, Fukuoka University, Nanakuma, Jonan-ku, Fukuoka, Japan
    • ,
  • Syed Shaheduzzaman

      Affiliations

    • Center for Prostate Disease Research, Department of Surgery and United States Military Cancer Institute, Uniformed Service University of the Health Science, Bethesda, Maryland
    • ,
  • Martin E. Nau

      Affiliations

    • Division of Retrovirology, Walter Reed Army Institute of Research, Rockville, Maryland
    • ,
  • Maryanne Vahey

      Affiliations

    • Division of Retrovirology, Walter Reed Army Institute of Research, Rockville, Maryland
    • ,
  • Gyorgy Petrovics

      Affiliations

    • Center for Prostate Disease Research, Department of Surgery and United States Military Cancer Institute, Uniformed Service University of the Health Science, Bethesda, Maryland
    • ,
  • David G. McLeod

      Affiliations

    • Center for Prostate Disease Research, Department of Surgery and United States Military Cancer Institute, Uniformed Service University of the Health Science, Bethesda, Maryland
    • Urology Service, Walter Reed Army Medical Center, Washington, District of Columbia
    • ,
  • Seiji Naito

      Affiliations

    • Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
    • ,
  • Senji Shirasawa

      Affiliations

    • Faculty of Medicine, Department of Cell Biology, Fukuoka University, Nanakuma, Jonan-ku, Fukuoka, Japan
    • ,
  • Shiv Srivastava

      Affiliations

    • Center for Prostate Disease Research, Department of Surgery and United States Military Cancer Institute, Uniformed Service University of the Health Science, Bethesda, Maryland
    • ,
  • Isabell A. Sesterhenn

      Affiliations

    • Center for Prostate Disease Research, Department of Surgery and United States Military Cancer Institute, Uniformed Service University of the Health Science, Bethesda, Maryland
    • Department of Genitourinary Pathology, Armed Forces Institute of Pathology, Washington, District of Columbia
    • Corresponding Author InformationReprint requests: Bungo Furusato, M.D., and Isabell A. Sesterhenn, M.D., Armed Forces Institute of Pathology, 6825 16 th Street NW, Washington, DC 20306

Received 3 July 2009 ,Accepted 15 October 2009.

References 

  1. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer. 1953;6:963–968
  2. Tuxhorn JA, Ayala GE, Rowley DR. Reactive stroma in prostate cancer progression. J Urol. 2001;166:2472–2483
  3. Hayward SW, Cunha GR, Dahiya R. Normal development and carcinogenesis of the prostate (A unifying hypothesis). Ann N Y Acad Sci. 1996;784:50–62
  4. Cunha GR, Hayward SW, Dahiya R, et al. Smooth muscle-epithelial interactions in normal and neoplastic prostatic development. Acta Anat. 1996;155:63–72
  5. Furusato B, Shaheduzzaman S, Petrovics G, et al. Transcriptome analyses of benign and malignant prostate epithelial cells in formalin-fixed paraffin-embedded whole-mounted radical prostatectomy specimens. Prostate Cancer Prostatic Dis. 2008;11:194–197
  6. Gleason DF. Classification of prostatic carcinomas. Cancer Chemother Rep. 1966;50:125–128
  7. Mostofi FK, Sesterhenn IA, Sobin LH. International Classification of Prostatic Tumors. Geneva: WHO; 1980;
  8. Sobin LH, Wittekind CH. In: TNM Classification of Malignant Tumors. 5th ed.. New York, NY: Wiley; 1997;
  9. Petrovics G, Liu A, Shaheduzzaman S, et al. Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome. Oncogene. 2005;24:3847–3852
  10. Zhang B, Kirov S, Snoddy JW Web. Gestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res. 2005;33:741–748
  11. Puglisi F, Puppin C, Pegolo E, et al. Expression of periostin in human breast cancer. J Clin Pathol. 2008;61:494–498
  12. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860–867
  13. Mueller MM, Fusenig NE. Friends or foes—bipolar effects of the tumour stroma in cancer. Nat Rev Cancer. 2004;4:839–849
  14. Bierie B, Moses HL. Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. Nat Rev Cancer. 2006;6:506–520
  15. Micke P, Ostman A. Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anticancer therapy?. Lung Cancer. 2004;45(suppl 2):S163–S175
  16. Barsky SH, Green WR, Grotendorst GR, et al. Desmoplastic breast carcinoma as a source of human myofibroblasts. Am J Pathol. 1984;115:329–333
  17. Ayala G, Tuxhorn JA, Wheeler TM, et al. Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer. Clin Cancer Res. 2003;9:4792–4801
  18. Rowley DR. What might a stromal response mean to prostate cancer progression?. Cancer Metastasis Rev. 1998;17:411–419
  19. Tuxhorn JA, Ayala GE, Smith MJ, et al. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. Clin Cancer Res. 2002;8:2912–2923
  20. McAlhany SJ, Ayala GE, Frolov A, et al. Decreased stromal expression and increased epithelial expression of WFDC1/ps20 in prostate cancer is associated with reduced recurrence-free survival. Prostate. 2004;61:182–191
  21. Ryan GB, Cliff WJ, Gabbiani G, et al. Myofibroblasts in human granulation tissue. Hum Pathol. 1974;5:55–67
  22. Olumi AF, Grossfeld GD, Hayward SW, et al. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res. 1999;59:5002–5011
  23. Tsunoda T, Furusato B, Takashima Y, et al. The increased expression of periostin during early stages of prostate cancer and advanced stages of cancer stroma. Prostate. 2009;69:1398–1403
  24. Gillan L, Matei D, Fishman DA, et al. Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility. Cancer Res. 2002;62:5358–5364
  25. Erkan M, Kleeff J, Gorbachevski A, et al. Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity. Gastroenterology. 2007;132:1447–1464
  26. Siriwardena BS, Kudo Y, Ogawa I, et al. Periostin is frequently overexpressed and enhances invasion and angiogenesis in oral cancer. Br J Cancer. 2006;95:1396–1403
  27. Baril P, Gangeswaran R, Mahon PC, et al. Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the beta4 integrin and the PI3K pathway. Oncogene. 2007;26:2082–2094
  28. Kudo Y, Ogawa I, Kitajima S, et al. Periostin promotes invasion and Anchorage-independent growth in the metastatic process of head and neck cancer. Cancer Res. 2006;66:6928–6935
  29. Sasaki H, Dai M, Auclair D, et al. Serum level of the periostin, a homologue of an insect cell adhesion molecule, as a prognostic marker in nonsmall cell lung carcinomas. Cancer. 2001;92:843–848
  30. Sasaki H, Lo KM, Chen LB, et al. Expression of Periostin, homologous with an insect cell adhesion molecule, as a prognostic marker in non-small cell lung cancers. Jpn J Cancer Res. 2001;92:869–873

 The views expressed in this article are those of the authors and do not reflect the official policy of the Department of the Army, Department of Defense, or the United States Government. Toshiyuki Tsunoda, Syed Shaheduzzaman, and Bungo Furusato contributed equally to this work.

PII: S0090-4295(09)02790-3

doi: 10.1016/j.urology.2009.10.026

Urology
Volume 75, Issue 4 , Pages 768-772 , April 2010

Article Tools

* Image Usage & Resolution